A liquid chromatography/tandem mass spectrometry assay for the analysis of atomoxetine in human plasma and in vitro cellular samples

作者：Appel David I; Brinda Bryan; Markowitz John S; Newcorn Jeffrey H; Zhu Hao Jie^*

来源：Biomedical Chromatography, 2012, 26(11): 1364-1370.

DOI：10.1002/bmc.2706

• atomoxetine
• LC-MS
• MS
• human plasma
• in vitro
• protein precipitation

A simple, rapid and sensitive method for quantification of atomoxetine by liquid chromatographytandem mass spectrometry (LC-MS/MS) was developed. This assay represents the first LC-MS/MS quantification method for atomoxetine utilizing electrospray ionization. Deuterated atomoxetine (d3-atomoxetine) was adopted as the internal standard. Direct protein precipitation was utilized for sample preparation. This method was validated for both human plasma and in vitro cellular samples. The lower limit of quantification was 3?ng/mL and 10?nm for human plasma and cellular samples, respectively. The calibration curves were linear within the ranges of 3900?ng/mL and 10?nm to 10?mu m for human plasma and cellular samples, respectively (r2?>?0.999). The intra- and inter-day assay accuracy and precision were evaluated using quality control samples at three different concentrations in both human plasma and cellular lysate. Sample run stability, assay selectivity, matrix effect and recovery were also successfully demonstrated. The present assay is superior to previously published LC-MS and LC-MS/MS methods in terms of sensitivity or the simplicity of sample preparation. This assay is applicable to the analysis of atomoxetine in both human plasma and in vitro cellular samples.

• 出版日期2012-11